Controlled Drugs and Substances Act & Regulations

Food and Drugs Act & Regulations

Amendments:

To the Food and Drug Regulations

Pre-notifications

Regulations Amending the Food and Drug Regulations (1447 - Good Manufacturing Practices) (October 11, 2006)
Amendment to the Food and Drug Regulations, Project No. 743, Non-medicinal Ingredients (August 14, 2006)
Regulations Amending the Food and Drug Regulations (1390 - Data Protection)
Regulations Amending the Food and Drug Regulations (1422 - Schedule F)
Regulations Amending the Food and Drug Regulations (1384 - Schedule F)
Regulations Amending the Food and Drug Regulations (1383 - Schedule F)
Regulations Amending the Food and Drug Regulations (1381 - Schedule F)
Regulations Amending the Food and Drug Regulations (1367 - Schedule F)
Regulations Amending the Food and Drug Regulations (1421 - Schedule F)
Notice of Intent to Develop Environmental Assessment Regulations for Products Regulated under The Food and Drugs Act

Canada Gazette - Part I

Canada Gazette - Part II

To Schedule F

Pre-notifications

Project 1682 Proposed Addition of Medicinal Ingredient Lacosamide and its derivatives to Schedule F (December 9, 2011)
Project 1682 Proposed Addition of Medicinal Ingredient Denozumab to Schedule F (December 9, 2011)
Project 1682 Proposed Addition of Medicinal Ingredient Febuxostat and its salts and derivatives to Schedule F (December 9, 2011)
Project 1682 Proposed Addition of Medicinal Ingredient Zucapsaicin to Schedule F (December 9, 2011)
Project 1713 Proposed Addition of Medicinal Ingredient Tolvaptan and its derivatives to Schedule F (November 25, 2011)
Project 1713 Proposed Addition of Medicinal Ingredient Telaprevir and its derivatives to Schedule F (November 25, 2011)
Project 1713 Proposed Addition of Medicinal Ingredient Colesevelam and its salts to Schedule F (November 25, 2011)
Project 1713 Proposed Addition of Medicinal Ingredient Asenapine, its salts and derivatives to Schedule F (November 25, 2011)
Project 1712 Proposed Addition of Medicinal Ingredient Ripilvirine, its salts and derivatives to Schedule F (November 25, 2011)
Project 1712 Proposed Addition of Medicinal Ingredient Linagliptin, its salts and derivatives to Schedule F (November 25, 2011)
Project 1712 Proposed Addition of Medicinal Ingredient Boceprevir and its derivatives to Schedule F (November 25, 2011)
Project 1712 Proposed Addition of Medicianl Ingredient Abiracetone acetate and its derivatives to Schedule F (November 25, 2011)
Project 1687 Proposed Addition of Medicinal Ingredient Clevidipine and its salts to Schedule F (July 26, 2011)
Project 1687 Proposed Addition of Medicinal Ingredient Belimumab to Schedule F (July 26, 2011)
Project 1684 Proposed Addition of Medicinal Ingredient Hydroxocobalamin and its salts when sold as a treatment for cyanide poisoning to Schedule F (April 21, 2011)
Project 1684 Proposed Addition of Medicinal Ingredient Eltrombopag and its salts to Schedule F (April 21, 2011)
Project 1670 Proposed Addition of Medicinal Ingredient Velaglucerase alfa to Schedule F (April 13, 2011)
Project 1670 Proposed Addition of Medicinal Ingredient Trabectedin, its salts and derivatives to Schedule F (April 13, 2011)
Project 1670 Proposed Addition of Medicinal Ingredient Roflumilast, its salts and derivatives to Schedule F (April 13, 2011)
Project 1670 Proposed Addition of Medicinal Ingredient Pazopanib and its salts to Schedule F (April 13, 2011)
Project 1670 Proposed Addition of Medicinal Ingredient Liraglutide and its salts to Schedule F (April 13, 2011)
Project 1670 Proposed Addition of Medicinal Ingredient Exenatide and its salts to Schedule F (April 13, 2011)
Project 1665 Proposed Addition of Medicinal Ingredient Sapropterin and its salts to Schedule F (July 27, 2010)
Project 1665 Proposed Addition of Medicinal Ingredient Prasugrel and its salts to Schedule F (July 27, 2010)
Project 1665 Proposed Addtion of Medicinal Ingredient Canakinumab to Schedule F (July 27, 2010)
Project 1665 Proposed Addition of Medicinal Ingredient Tocilizumab to Schedule F (July 27, 2010)
Project #1621 Proposed Additon of 4 Medicinal Ingredients (Dirlotapide, Firocoxib, Ibafloxacin and Maripotant and its salts) to Schedule F (February 2, 2010)
Project #1652 Notice of Intent to Amend Schedule F (L-asparaginase) (December 24, 2009)
Project #1659 Proposed Addition of Medicinal Ingredient Dronedarone to Schedule F (December 10, 2009)
Project #1659 Proposed Addition of Medicinal Ingredient Degarelix to Schedule F (December 10, 2009)
Project #1659 Proposed Addition of Medicinal Ingredient Clofarabine to Schedule F (December 10, 2009)
Project #1659 Proposed Addition of Medicinal Ingredient Azacitidine to Schedule F (December 10, 2009)
Project #1659 Proposed Addition of Medicinal Ingredient Urokinase to Schedule F (December 10, 2009)
Project #1658 Proposed Addition of Medicinal Ingredient Doripenem and its salts and derivatives (December 10, 2009)
Project #1658 Proposed Addition of Medicinal Ingredient Besifloxacin and its salts to Schedule F (December 10, 2009)
Project #1658 Proposed Addition of Medicinal Ingredient Alitretinoin and its salts and derivatives to Schedule F (December 10, 2009)
Project #1658 Proposed Addition of Medicinal Ingredient Saxagliptin and its salts to Schedule F (December 10, 2009)
Project #1659 Proposed Addition of Medicinal Ingredient Certolizumab Pegol to Schedule F (October 5, 2009)
Project #1659 Proposed Addition of Medicinal Ingredient Aripiprazole and its salts (October 5, 2009)
Project #1597 Proposed Addition of 3 medicinal ingredients (Idebenone, Idursulfase, Nesiritide) to Schedule F (October 1, 2009)
Project #1623 Proposed Addition of 4 medicinal ingredients (Desvenlafaxine and its salts, Eplerenone, Fosaprepitant and its salts and Moclobemide) to Schedule F (September 24, 2009)
Project #1625 RESCINDED Medical Ingredient Hyoscine and its salts and derivatives (September 1, 2009)
Project #1623 REVISED Medicinal Ingredient Fosaprepitant and its salts to Schedule F (July 15, 2009)
Project #1623 REVISED Medicinal Ingredient (Eplerenone) to Schedule F (July 15, 2009)
Project #1623 REVISED Medicinal Ingredient (Desvenlafaxine and its salts) to Schedule F (July 15, 2009)
Project #1626 Proposed Addition of 1 Medicinal Ingredient (Collagenase) to Schedule F (June 10, 2009)
Project #1625 Proposed Addition of 1 Medicinal Ingredient (Hyoscine and its salts and derivatives) to Schedule F (June 9, 2009)
Project #1623 Proposed Addition of 4 Medicinal Ingredients (Aprepitant and its salts and derivatives, Moclobemide, Spironolactone and its derivatives, and Venlafaxine and its salts and derivatives) to Schedule F (May 12, 2009)
Project #1597 Proposed Addition of 1 Medicinal Ingredient (Idursulfase) to Schedule F (February 17, 2009)
Project #1597 Proposed Addition of 1 Medicinal Ingredient (Nesiritide) to Schedule F (February 17, 2009)
Project #1597 Proposed Addition of 1 Medicinal Ingredient (Idebenone) to Schedule F (December 9, 2008)
Project #1578 Proposed Addition of 1 Medicinal Ingredient (Acamprosate) to Schedule F (November 15, 2007)
Project #1441: Proposed Addition of 1 Medicinal Ingredient (Zaleplon) to Schedule F (August 17, 2006)
Project #1431: Proposed Addition of 1 Medicinal Ingredient (Quinine and its salts and derivatives) to Schedule F (May 29, 2006)
Project #1405: Proposed Addition of 7 Medicinal Ingredients (Atazanavir and its salts; Fulvestrant; Gefitinib; Gemifloxacin and its salts; Hetastarch and its derivatives; Ibandronic acid and its salts; Ponazuril) to Schedule F (November 15, 2005)
Schedule 1397: Schedule F Update (January 2004)

Canada Gazette - Part I

Project 1431 Proposed Addition of one medicinal ingredient (Quinine, its salts and derivatives except in oral dosage form that provides 50 mg or less of quinine base per dosage unit or per daily dose) (March 26, 2011)
Project #1554: Proposed Addition of one medicinal ingredient, (Progesterone and its derivatives except when sold in an implant for veterinary use for growth promotion) (January 19, 2008)
Schedule 1385: Vitamin K (January 2004/April 2005)
Schedule 1203: Addition of nine new drug substances (Feburary 2000)
Zaleplon, Zolpidem, Zopiclone (June 29/02)

Canada Gazette Part II

To the Natural Health Products Regulations

Canada Gazette - Part II

Regulations Amending the Natural Health Products Regulations (Vitamin K) (October 19, 2005)
Regulations amending the NHPR (Special Access) - June 2004

Related Documents